Impact Biomedical (IBO) 10% Owner DSS, Inc. Sells Shares

What Happened DSS, Inc., reported as a 10% owner of Impact Biomedical, disposed of a total of 906 shares of IBO common stock in three open‑market sales between Sept 22 and Sept 24, 2026. The individual transactions were: 723 shares at $0.55 ($398), 27 shares at $6.95 ($188), and 156 shares at $7.06 ($1,101), for aggregate proceeds of approximately $1,687. These were sales (transaction code S), not purchases.

Key Details

• Transaction dates and prices:
  • 2026-09-22: 723 shares @ $0.55 = $398
  • 2026-09-23: 27 shares @ $6.95 = $188
  • 2026-09-24: 156 shares @ $7.06 = $1,101
• Total disposed: 906 shares for ~$1,687.
• Insider status: DSS, Inc. is reported as a 10% owner; the filing notes the trading entity is a wholly‑owned subsidiary of DSS, Inc.
• Shares owned after the transactions: not specified in the information provided.
• Filing timeliness: Form 4 was filed on 2026-09-24 for transactions on 9/22–9/24; this appears to be filed within the usual 2-business‑day reporting window.
• Transaction code explanation: S = Sale (disposition of shares).

Context

• This report reflects institutional/owner disposals by a 10% holder (through a subsidiary), not an individual executive; such sales can be routine and do not by themselves indicate company prospects.
• No exercise, award, gift, or tax‑withholding detail is reported here — just open‑market sales.